Recombinant collagen creams heat up: Three things practitioners should watch

Recombinant collagen creams heat up has been gaining momentum. Data shows that in Q2, top-brand concentration rose to RMB 2.34bn, and industry attention is clearly rising. This piece breaks down three things practitioners should watch using public information and platform data.

Competitively, moves by leaders such as HBN are a bellwether. Performance in Japan deserves particular attention, as shifts in channel and audience structure are reshaping growth logic.

Two signals stand out from HBN’s latest moves: resources keep concentrating at the top, while incremental markets like Japan gain bargaining power.

For practitioners, three directions follow: differentiate product and content back to R&D and supply chain; build localisation capability for markets such as Japan; and treat compliance and data capability as the new moat.

Bottom line: recombinant collagen creams heat up is moving from concept to execution — three things practitioners should watch. Brands should review strategy before Q2 and prioritise channels and segments with higher certainty.

Related